Monoclonal antibody production
Use hybridoma cell lines as stable sources of clone-specific antibodies.
Monoclonal Antibodies
Hybridomas are immortalized antibody-producing cell lines created by fusing antibody-secreting B cells with compatible myeloma cells. Each hybridoma clone can produce a monoclonal antibody with defined target specificity, making hybridoma technology a classic foundation for reproducible antibody generation. Hybridoma-derived monoclonal antibodies are used in research, immunoassay development, target validation, protein detection, flow cytometry, western blotting, immunohistochemistry and other workflows where stable clone identity and consistent antibody production are important.

Product catalog
Showing 0 unique product names from this subcategory.
No products found for this subcategory.
Please contact Gentaur support if you need help finding a specific product.
Overview
Hybridoma technology enables long-term production of clone-derived antibodies. Once a useful clone is selected, the cell line can provide a stable source of monoclonal antibody for repeated experiments.
Hybridomas are important in antibody screening because each clone can be evaluated for target specificity, affinity, isotype, application performance and background behavior.
Researchers working with hybridoma-derived antibodies should review clone name, isotype, host species, target validation, culture conditions, purification method and application data.
Applications
Use hybridoma cell lines as stable sources of clone-specific antibodies.
Evaluate antibody-producing clones for specificity, signal strength and application performance.
Use hybridoma-derived antibodies as capture, detection or reference reagents in immunoassays.
Support reproducible target detection across western blot, ELISA, IHC, IF or flow cytometry workflows.
Analyze isotype, affinity, specificity, epitope recognition and cross-reactivity of selected clones.
Selection guide
Select hybridoma-related products according to clone identity, antibody specificity, isotype, production format and application validation.
Confirm clone name, origin, target specificity and whether the clone has supporting validation data.
Hybridoma antibodies are often mouse or rat-derived, and isotype affects purification and detection strategy.
Check whether the antibody is validated for ELISA, western blot, IHC, IF, ICC, flow cytometry or immunoprecipitation.
Determine whether the product is purified antibody, culture supernatant, ascites-derived material or a live cell line resource.
Review purity, concentration, formulation buffer, preservatives and storage conditions.
Track clone, lot number, concentration, passage information and validation conditions across experiments.
FAQ
Common questions about hybridoma-derived monoclonal antibodies and cell line hosts.
A hybridoma is an immortalized cell line created by fusing an antibody-producing B cell with a myeloma cell, allowing continuous monoclonal antibody production.
They provide stable clone-derived antibody production, helping researchers obtain reproducible antibody reagents.
A hybridoma clone is a selected cell line that produces one monoclonal antibody with defined target specificity.
Many classic hybridoma antibodies are mouse-derived, but hybridoma workflows can also involve other compatible host systems.
Check clone identity, isotype, target validation, application data, purification method, concentration and storage conditions.
Related categories